Patents by Inventor Eamonn P. Hobbs
Eamonn P. Hobbs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240102993Abstract: A method for optimal selection of cytotoxic agents for organ or region specific therapy that includes extracorporeal filtration of the cytotoxic agent from blood drained from the organ or region being treated and return of the filtered blood to a mammal is disclosed.Type: ApplicationFiled: November 29, 2023Publication date: March 28, 2024Applicant: Delcath Systems, Inc.Inventors: Eamonn P. Hobbs, Daniel S. Johnston
-
Patent number: 11867686Abstract: A method for optimal selection of cytotoxic agents for organ or region specific therapy that includes extracorporeal filtration of the cytotoxic agent from blood drained from the organ or region being treated and return of the filtered blood to a mammal is disclosed.Type: GrantFiled: June 4, 2020Date of Patent: January 9, 2024Assignee: Delcath Systems, Inc.Inventors: Eamonn P. Hobbs, Daniel S. Johnston
-
Publication number: 20230404642Abstract: The present disclosure provides, among other things, methods of cancer treatment comprising steps of: a) intratumoral cell lysis, mediated by cryolysis; and b) intratumoral administration of 1) a combination of immunotherapeutic agents comprising: i) a TLR9 agonist CpG oligodeoxydinucleotide, ii) an agonistic anti-CD40 monoclonal antibody, iii) an agonistic anti-OX40 monoclonal antibody and iv) an anti-CTLA4 monoclonal antibody; or 2) a combination of immunotherapeutic agents comprising: i) a TLR9 agonist CpG oligodeoxydinucleotide, ii) an agonistic anti-CD40 monoclonal antibody, iii) an anti-PD1 monoclonal antibody and iv) an anti-CTLA4 monoclonal antibody.Type: ApplicationFiled: June 1, 2023Publication date: December 21, 2023Inventors: Charles J. Link, JR., Jason R. Williams, Mario R. Mautino, Daniel K. Recinelia, Eamonn P. Hobbs
-
Publication number: 20200300839Abstract: A method for optimal selection of cytotoxic agents for organ or region specific therapy that includes extracorporeal filtration of the cytotoxic agent from blood drained from the organ or region being treated and return of the filtered blood to a mammal is disclosed.Type: ApplicationFiled: June 4, 2020Publication date: September 24, 2020Applicant: Delcath Systems, Inc.Inventors: Eamonn P. Hobbs, Daniel S. Johnston
-
Patent number: 9782562Abstract: A method of treating varicose veins and other vascular diseases provides sclerosant fluid through a catheter into the body vessel to be treated. The catheter has a lumen and a plurality of sidewall exits. The sclerosant fluid is provided under sufficient pressure so that it comes out of each exit as a jet of fluid with sufficient velocity to impinge on the vessel wall substantially orthogonal to the wall and thus minimize dilution of the sclerosant fluid and optimize coverage. A movable sheath on the catheter permits selecting a portion of the exits to be uncovered and thus create an infusion zone for the jets of sclerosant fluid which approximately match a desired treatment zone.Type: GrantFiled: January 6, 2016Date of Patent: October 10, 2017Inventors: Eamonn P Hobbs, William M Appling
-
Publication number: 20170106167Abstract: The method of treating varicose veins and other vascular diseases provides sclerosant fluid through a catheter into the body vessel to be treated. The catheter has a lumen and a plurality of sidewall exits. The sclerosant fluid is provided under sufficient pressure so that it comes out of each exit as a jet of fluid with sufficient velocity to impinge on the vessel wall substantially orthogonal to the wall and thus minimize dilution of the sclerosant fluid and optimize coverage. A movable sheath on the catheter permits selecting a portion of the exits to be uncovered and thus create an infusion zone for the jets of sclerosant fluid which approximately match a desired treatment zone.Type: ApplicationFiled: September 20, 2016Publication date: April 20, 2017Applicant: AngioDynamics, Inc.Inventors: Eamonn P Hobbs, William M Appling
-
Patent number: 9541544Abstract: A method for optimal selection of cytotoxic agents for organ or region specific therapy that includes extracorporeal filtration of the cytotoxic agent from blood drained from the organ or region being treated and return of the filtered blood to a mammal is disclosed.Type: GrantFiled: August 28, 2013Date of Patent: January 10, 2017Assignee: Delcath Systems, Inc.Inventors: Eamonn P. Hobbs, Daniel S. Johnston
-
Publication number: 20160192944Abstract: The method of treating varicose veins and other vascular diseases provides sclerosant fluid through a catheter into the body vessel to be treated. The catheter has a lumen and a plurality of sidewall exits. The sclerosant fluid is provided under sufficient pressure so that it comes out of each exit as a jet of fluid with sufficient velocity to impinge on the vessel wall substantially orthogonal to the wall and thus minimize dilution of the sclerosant fluid and optimize coverage. A movable sheath on the catheter permits selecting a portion of the exits to be uncovered and thus create an infusion zone for the jets of sclerosant fluid which approximately match a desired treatment zone.Type: ApplicationFiled: January 6, 2016Publication date: July 7, 2016Applicant: AngioDynamics, Inc.Inventors: Eamonn P Hobbs, William M Appling
-
Patent number: 9173704Abstract: An indwelling venous catheter and method capable of destroying undesirable cellular growth is provided. The catheter includes a shaft having at least one lumen and adapted to be placed inside a vein for long term use. A plurality of electrodes are positioned near a distal section of the shaft and are adapted to receive from a voltage generator a plurality of electrical pulses in an amount sufficient to cause destruction of cells in the undesirable cellular growth that have grown around the shaft. In one aspect of the invention, a probe is configured to be removably insertable into the at least one lumen and the electrodes are positioned near the distal section of the probe.Type: GrantFiled: June 19, 2009Date of Patent: November 3, 2015Assignee: AngioDynamics, Inc.Inventors: Eamonn P. Hobbs, William C. Hamilton, Jr.
-
Patent number: 8562588Abstract: A method and device are herein described to treat a target region of tissue, using at least one energy delivery device coupled to a power source and positioned in a treatment position so as to irreversibly electroporate tissue to ablate a target region, and introduce regenerative materials into a treated region.Type: GrantFiled: July 24, 2012Date of Patent: October 22, 2013Assignee: AngioDynamics, Inc.Inventors: Eamonn P. Hobbs, James G. Lovewell, Robert M. Pearson
-
Publication number: 20120289888Abstract: A method and device are herein described to treat a target region of tissue, using at least one energy delivery device coupled to a power source and positioned in a treatment position so as to irreversibly electroporate tissue to ablate a target region, and introduce regenerative materials into a treated region.Type: ApplicationFiled: July 24, 2012Publication date: November 15, 2012Inventors: Eamonn P. Hobbs, James G. Lovewell, Robert M. Pearson
-
Patent number: 8231603Abstract: A method and device are herein described to treat a target region of tissue, using at least one energy delivery device coupled to a power source and positioned in a treatment position so as to irreversibly electroporate tissue to ablate a target region, and introduce regenerative materials into a treated region.Type: GrantFiled: February 10, 2010Date of Patent: July 31, 2012Assignee: AngioDynamics, Inc.Inventors: Eamonn P. Hobbs, James G. Lovewell, Robert M. Pearson
-
Patent number: 8057460Abstract: A multiple tube catheter, such as a hemo-dialysis catheter, has first and second tubes which are attached to each other over a zone by one or more longitudinally extending wires which joins the two tubes over that zone. When a catheter is implanted in the patient, the attached zone is within the patient so that the catheter cannot be removed or advanced. When the catheter is to be removed, the longitudinally extending wire or wires are pulled proximally out of the tubes involved so that the two tubes can be separated and individually removed. A flexible separating prong within the patient and proximal of the zone holds the tubes apart to further assure that the catheter cannot be moved.Type: GrantFiled: October 22, 2007Date of Patent: November 15, 2011Assignee: AngioDynamics, IncInventors: Eamonn P. Hobbs, William M. Appling, Angelo J. Tarricone, Theodore J. Beyer
-
Publication number: 20100204638Abstract: A method and device are herein described to treat a target region of tissue, using at least one energy delivery device coupled to a power source and positioned in a treatment position so as to irreversibly electroporate tissue to ablate a target region, and introduce regenerative materials into a treated region.Type: ApplicationFiled: February 10, 2010Publication date: August 12, 2010Applicant: ANGIODYNAMICS, INC.Inventors: Eamonn P. Hobbs, James G. Lovewell, Robert M. Pearson
-
Publication number: 20100152725Abstract: A system for selectively ablating tissue is provided herein that has at least one energy source that has a non-thermal energy source and a thermal energy source, at least one probe, means for selectively coupling the probe to one desired energy source of the at least one energy source, means for selectively energizing the non-thermal energy source of the at least one energy source to apply non-thermal energy to at least a portion of the desired region to ablate at least a portion of the desired region, and means for selectively energizing the thermal energy source of the at least one energy source during the withdrawal of the at least one probe to thermally ablate tissue substantially adjacent to a probe track.Type: ApplicationFiled: November 30, 2009Publication date: June 17, 2010Applicant: AngioDynamics, Inc.Inventors: Robert M. Pearson, Eamonn P. Hobbs, William M. Appling
-
Publication number: 20090318849Abstract: An indwelling venous catheter and method capable of destroying undesirable cellular growth is provided. The catheter includes a shaft having at least one lumen and adapted to be placed inside a vein for long term use. A plurality of electrodes are positioned near a distal section of the shaft and are adapted to receive from a voltage generator a plurality of electrical pulses in an amount sufficient to cause destruction of cells in the undesirable cellular growth that have grown around the shaft. In one aspect of the invention, a probe is configured to be removably insertable into the at least one lumen and the electrodes are positioned near the distal section of the probe.Type: ApplicationFiled: June 19, 2009Publication date: December 24, 2009Inventors: Eamonn P. Hobbs, William C. Hamilton, JR.
-
Publication number: 20080208236Abstract: A dermal marking and a method of identifying the characteristics of an implanted medical device using the dermal marking. The method involves providing an implantable medical device, implanting a medical device in a patient, providing at least one dermal marking that contains information disclosing at least one characteristic of the implanted medical device, applying the at least one dermal marking to the skin of the patient, perceiving the dermal marking on the patient's skin, and identifying at least one characteristic of the implantable medical device based on the dermal marking.Type: ApplicationFiled: February 28, 2008Publication date: August 28, 2008Applicant: AngioDynamics, Inc.Inventors: Eamonn P. Hobbs, William M. Appling
-
Patent number: 7347852Abstract: A multiple tube catheter, such as a hemo-dialysis catheter, has first and second tubes which are attached to each other over a zone by one or more longitudinally extending wires which joins the two tubes over that zone. When a catheter is implanted in the patient, the attached zone is within the patient so that the catheter cannot be removed or advanced. When the catheter is to be removed, the longitudinally extending wire or wires are pulled proximally out of the tubes involved so that the two tubes can be separated and individually removed. A flexible separating prong within the patient and proximal of the zone holds the tubes apart to further assure that the catheter cannot be moved.Type: GrantFiled: November 20, 2001Date of Patent: March 25, 2008Assignee: AngioDynamics, Inc.Inventors: Eamonn P. Hobbs, William M. Appling, Angelo J. Tarricone, Theodore J. Beyer
-
Publication number: 20030097091Abstract: A multiple tube catheter, such as a hemo-dialysis catheter, has first and second tubes which are attached to each other over a zone by one or more longitudinally extending wires which joins the two tubes over that zone. When a catheter is implanted in the patient, the attached zone is within the patient so that the catheter cannot be removed or advanced. When the catheter is to be removed, the longitudinally extending wire or wires are pulled proximally out of the tubes involved so that the two tubes can be separated and individually removed. A flexible separating prong within the patient and proximal of the zone holds the tubes apart to further assure that the catheter cannot be moved.Type: ApplicationFiled: November 20, 2001Publication date: May 22, 2003Inventors: Eamonn P. Hobbs, William M. Appling, Angelo J. Tarricone, Theodore J. Beyer
-
Patent number: 5439449Abstract: A needle system which upon arterial entry provides a visual indication of pulsatile blood flow. The needle system includes an elongated needle with distal and proximal ends. There is a needle hub at the proximal end of the needle and a port position between the proximal needle end and proximal hub end. The visualization connector tube having two ends is provided. The tube is sufficiently clear to permit visualization of material held therein. The first end of the tube is in communication with the port. An elastomeric reservoir is provided. The reservoir is in free, direct, unrestricted two-way communication with a second tube end. The needle, needle hub, and tube all have predetermined volumes. The reservoir has an initial unexpanded state with a first pressure and a first volume and a second state expanded with a second pressure and a second volume. Air pressure in the needle system is increased upon arterial entry.Type: GrantFiled: April 22, 1994Date of Patent: August 8, 1995Assignee: E-Z-Em, Inc.Inventors: Harold C. Mapes, William M. Appling, Michael P. Cody, Eamonn P. Hobbs